Characteristics and outcome of congenital mesoblastic nephroma: A report of 376 patients registered in the SIOP 93-01, SIOP WT 2001, UK-IMPORT, and AIEOP protocols
PLOS One · 26.05.2026 · 21 (5) · e0349345
DOI: 10.1371/journal.pone.0349345 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 26.05.2026. Verfasst von Paola Quarello und 27 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Turin, Italy. Hauptthemen laut MEDLINE: Nephroma, Mesoblastic, Kidney Neoplasms. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Congenital mesoblastic nephroma (CMN) is the most common renal neoplasm diagnosed in the very first months of life. Complete nephrectomy only is the gold standard treatment. Objectives and methods This retrospective study aimed to explore the characteristics and outcome of CMN patients registered in the SIOP 93–01, SIOP WT 2001, UK-IMPORT, and AIEOP studies (1993–2019).
Results
A total of 376 CMN cases were identified, with a median age at diagnosis of 28 days. Stage information was available for 337 patients: 92/337 (27.4%) were diagnosed with stage I, 177/337 (52.6%) with stage II, and 67/337 (20%) with stage III. Among 272 patients with available histological data, 113/272 (41.5%) had classic, 105/272 (38.6%) cellular, and 54/272 (19.9%) mixed subtype. Treatment details were available for 314 patients; 248 (79%) underwent initial surgery, and 66 (21%) received preoperative chemotherapy. Among the latter group, 60% of patients showed a measurable reduction in tumor volume, indicating a favorable response to chemotherapy. The 5-year event-free survival rate was 93.8%, and the overall survival rate was 96.9%. The cumulative 5-year incidence of relapse was 5.3%, with a median time to recurrence of 4 months. Of the 16 relapse cases, 8 were in the cellular subtype, 5 in the mixed subtype, and 3 in the classical subtype.
Conclusions
This study confirms that CMN patients have an excellent outcome, with complete surgical resection being curative in the majority of cases. Chemosensitivity is observed in a significant proportion, suggesting that neoadjuvant chemotherapy may be a viable option in selected cases. While age at diagnosis, histological subtype, and survival outcomes are consistent with previous reports, we highlight that recurrences, though infrequent, tend to occur early and are not restricted to the cellular subtype. Further prospective studies and molecular investigations are required to refine clinical management strategies and update treatment recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Turin, Italy.
- Department of Pediatric and Public Health Sciences, University of Turin, Turin, Italy.
- Princess Máxima Centre for Pediatric Oncology, Utrecht, The Netherlands.
- Department of Hematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
- La Timone, Children's Hospital, Pediatric Oncology Department, APHM, Marseille, France.
- Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Paola Quarello, Arnauld Verschuur, Annalisa Serra, Nuno Jorge Dos Reis Farinha, Martine van Grotel, Gema Lucia Ramirez-Villar, Rhoikos Furtwängler, Norbert Graf, Marry van den Heuvel-Eibrink
Zitieren
APA
Quarello, P., Dandis, R., Chowdhury, T., Verschuur, A., Brok, J., Vujanic, G., Vokuhl, C., Collini, P., Coulomb, A., Serra, A., Biasoni, D., Flores, P., Kager, L., Segers, H., Malić Tudor, K., Burman, M. M., Dos Reis Farinha, N. J., Romerius, P., Godzinski, J., …, & van den Heuvel-Eibrink, M. (2026). Characteristics and outcome of congenital mesoblastic nephroma: A report of 376 patients registered in the SIOP 93-01, SIOP WT 2001, UK-IMPORT, and AIEOP protocols. PLOS One, 21(5), e0349345. https://doi.org/10.1371/journal.pone.0349345
Vancouver
Quarello P, Dandis R, Chowdhury T, Verschuur A, Brok J, Vujanic G, et al. Characteristics and outcome of congenital mesoblastic nephroma: A report of 376 patients registered in the SIOP 93-01, SIOP WT 2001, UK-IMPORT, and AIEOP protocols. PLOS One. 2026;21(5):e0349345. doi:10.1371/journal.pone.0349345
BibTeX
@article{Quarello2026,
author = {Quarello, Paola and Dandis, Rana and Chowdhury, Tanzina and Verschuur, Arnauld and Brok, Jesper and Vujanic, Gordan and Vokuhl, Christian and Collini, Paola and Coulomb, Aurore and Serra, Annalisa and Biasoni, Davide and Flores, Paula and Kager, Leo and Segers, Heidi and Malić Tudor, Karolina and Burman, Marta Maria and Dos Reis Farinha, Nuno Jorge and Romerius, Patrik and Godzinski, Jan and van Grotel, Martine and Ramirez-Villar, Gema Lucia and De Camargo, Beatriz and Furtwängler, Rhoikos and Al-Saadi, Reem and Van Tinteren, Harm and Graf, Norbert and Spreafico, Filippo and van den Heuvel-Eibrink, Marry},
title = {Characteristics and outcome of congenital mesoblastic nephroma: A report of 376 patients registered in the SIOP 93-01, SIOP WT 2001, UK-IMPORT, and AIEOP protocols},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0349345},
doi = {10.1371/journal.pone.0349345}
}
EUVIMED